Sepsis Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Sepsis Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  • Transparency Market Research
  • April 2021
  • Pharmaceutical
  • 188 pages

Report Description

Sepsis Treatment Market – Scope of the Report

TMR’s report on the global sepsis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global sepsis treatment market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global sepsis treatment market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global sepsis treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global sepsis treatment market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global sepsis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global sepsis treatment market. The next section of the global sepsis treatment market report highlights the USPs, which include technological advancements, key industry events (mergers, acquisitions, strategic partnerships, etc.), top three players operating in the market space, and COVID-19 pandemic impact on the global sepsis treatment market.

The report delves into the competitive landscape of the global sepsis treatment market. Key players operating in the global sepsis treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global sepsis treatment market report.

Key Questions Answered in Sepsis Treatment Market Report

  • What are the sales/revenue generated by sepsis manufacturers across all regions during the forecast period?
  • What are the key trends in the global sepsis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2031 and which segment will expand at the highest CAGR during the forecast period?
  • What was the market ranking of different companies operating in the global market in 2020?

Sepsis Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global sepsis treatment market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global sepsis treatment market. It is followed by market introduction, market dynamics, and an overview of the global sepsis treatment market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global sepsis treatment market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global sepsis treatment market in terms of value. The forecast presented here assesses the total revenue generated in the global sepsis treatment market. In order to provide an accurate forecast, we initiated by sizing of the current sepsis treatment market with the help of the parent market.

The report analyzes the global sepsis treatment market in terms of type, therapy, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global sepsis treatment market.

Keywords

  • Sepsis Treatment Market
  • Sepsis Treatment Market Share
  • Demand for Sepsis Treatment
  • Sales of Sepsis Treatment
  • Sepsis Treatment Sales Demand
  • Sepsis Treatment Market Forecast
  • Sepsis Treatment Sales Forecast
  • Sepsis Treatment Demand forecast
  • US Sepsis Treatment Market
  • Canada Sepsis Treatment Market
  • Europe Sepsis Treatment Market
  • Middle East Sepsis Treatment market

Companies Mentioned

  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA 
  • Nipro Corporation
  • Asahi Kasei 
  • B. Braun Group
  • CytoSorbents Corporation
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Medica SPA
  • Toray Industries
  • Merck & Co., Inc

Have query on this report?

Make an Enquiry

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sepsis Treatment Market


4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sepsis Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Sepsis Population (admissions as % of population)
5.2. Total Sepsis Hospital Admissions [general ward & other, ICU patients admitted (000)]
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Sepsis Treatment Market Analysis and Forecast, by Type 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
6.3.1. Severe Sepsis
6.3.2. Septic Shock
6.3.3. Sepsis in Need of Blood Purification
6.4. Global Sepsis Treatment Market Attractiveness Analysis, by Type

7. Global Sepsis Treatment Market Analysis and Forecast, by Therapy 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
7.3.1. Continuous Renal Replacement Therapies (CRRT)
7.3.2. Intermittent Hemodialysis
7.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
7.3.4. Others
7.4. Global Sepsis Treatment Market Attractiveness Analysis, by Therapy 

8. Global Sepsis Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Centers
8.3.3. Others
8.4. Global Sepsis Treatment Market Attractiveness Analysis, by End-user 

9. Global Sepsis Treatment Market Analysis and Forecast, by Region 
9.1. Key Findings
9.2. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Region
9.2.1. North America
9.2.2. Europe 
9.2.3. Asia Pacific
9.2.4. Latin America 
9.2.5. Middle East & Africa
9.3. Global Sepsis Treatment Market Attractiveness Analysis, by Region

10. North America Sepsis Treatment Market Analysis and Forecast
10.1.  Introduction
10.1.1.  Key Findings
10.2. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type , 2017–2031
10.2.1. Severe Sepsis
10.2.2. Septic Shock
10.2.3. Sepsis in Need of Blood Purification
10.3. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
10.3.1. Continuous Renal Replacement Therapies (CRRT)
10.3.2. Intermittent Hemodialysis
10.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
10.3.4. Others
10.4. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Centers
10.4.3. Others
10.5. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Sepsis Treatment Market Attractiveness Analysis
10.6.1. By Type 
10.6.2. By Therapy 
10.6.3. By End-user
10.6.4. By Country

11. Europe Sepsis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
11.2.1. Severe Sepsis
11.2.2. Septic Shock
11.2.3. Sepsis in Need of Blood Purification
11.3. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
11.3.1. Continuous Renal Replacement Therapies (CRRT)
11.3.2. Intermittent Hemodialysis
11.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
11.3.4. Others
11.4. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Centers
11.4.3. Others
11.5. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Sepsis Treatment Market Attractiveness Analysis
11.6.1. By Type 
11.6.2. By Therapy 
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Sepsis Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
12.2.1. Severe Sepsis
12.2.2. Septic Shock
12.2.3. Sepsis in Need of Blood Purification
12.3. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
12.3.1. Continuous Renal Replacement Therapies (CRRT)
12.3.2. Intermittent Hemodialysis
12.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
12.3.4. Others
12.4. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Centers
12.4.3. Others
12.5. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India 
12.5.4. Australia & New Zealand 
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Sepsis Treatment Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Therapy 
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Sepsis Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
13.2.1. Severe Sepsis
13.2.2. Septic Shock
13.2.3. Sepsis in Need of Blood Purification
13.3. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
13.3.1. Continuous Renal Replacement Therapies (CRRT)
13.3.2. Intermittent Hemodialysis
13.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
13.3.4. Others
13.4. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Centers
13.4.3. Others
13.5. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Sepsis Treatment Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Therapy
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Middle East & Africa Sepsis Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
14.2.1. Severe Sepsis
14.2.2. Septic Shock
14.2.3. Sepsis in Need of Blood Purification
14.3. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
14.3.1. Continuous Renal Replacement Therapies (CRRT)
14.3.2. Intermittent Hemodialysis
14.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
14.3.4. Others
14.4. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Centers
14.4.3. Others
14.5. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries 
14.5.2. South Africa 
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Sepsis Treatment Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Therapy 
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competitive Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2.  Company Profiles
15.2.1. Baxter International, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Fresenius Medical Care AG & Co. KGaA 
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Nipro Corporation
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Asahi Kasei 
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. B. Braun Group
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. CytoSorbents Corporation
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Medtronic plc
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Nikkiso Co., Ltd.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. Medica SPA
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Toray Industries
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. Merck & Co., Inc.
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Financial Overview
15.2.11.3. Product Portfolio
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis

List of Tables

Table 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 03: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 08: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 12: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 16: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 20: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 24: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Success Stories

Our Clients